| 4,6-Pyrimidinediamine, N4-cyclohexyl-N6-(4-methoxyphenyl)- |
化合物VUT-MK142 |
1313491-22-3 |
| AZD-2858 |
AZD2858 |
486424-20-8 |
| RPW-24 |
RPW-24 |
1001625-82-6 |
| 1H-Benzimidazole, 2-(2-pyridinyl)-6-(trifluoromethoxy)- |
化合物AI-10-47 |
1256094-31-1 |
| KEA1-97 |
KEA1-97 |
2138882-71-8 |
| SKL 2001 |
SKL2001 |
909089-13-0 |
| IMR-1 |
[2-甲氧基-4-[(4-氧代-2-硫代-5-噻唑烷亚基)甲基]苯氧基]乙酸乙酯 |
310456-65-6 |
| (Z)-1-(2-Chloro-2-(2,4-dichlorophenyl)ethenyl)-(1H)-1,2,4-triazolehydrochloride |
氯瑞唑 |
117857-45-1 |
| VidofludiMus |
维多氟拉迪莫 |
717824-30-1 |
| SR-95531 |
克他命 |
104104-50-9 |
| SKI II |
鞘氨醇激酶抑制剂 |
312636-16-1 |
| (2R)-1-[[5-[(Z)-[5-[[(2,6-DICHLOROPHENYL)METHYL]SULFONYL]-1,2-DIHYDRO-2-OXO-3H-INDOL-3-YLIDENE]METHYL]-2,4-DIMETHYL-1H-PYRROL-3-YL]CARBONYL]-2-(1-PYRROLIDINYLMETHYL)PYRROLIDINE |
(2R)-1-[[5-[(Z)-[5-[[(2,6-二氯苯基)甲基]磺酰]-1,2-二氢-2-氧代-3H-吲哚-3-亚基]甲基]-2,4-二甲基-1H-吡咯-3-基]羰基]-2-(1-吡咯烷甲基)吡咯烷 |
477575-56-7 |
| Riociguat |
利奥西呱 |
625115-55-1 |
| RESIQUIMOD |
雷西莫特 |
144875-48-9 |
| IKK Inhibitor III, BMS-345541 |
BMS-345541 |
445430-58-0 |
| IC 261 |
3-(2,4,6-三甲氧基苯亚甲基)吲哚啉-2-酮 |
186611-52-9 |
| 2-[[(2E)-3-(2-NAPHTHALENYL)-1-OXO-2-BUTEN-1-YL]AMINO]BENZOIC ACID |
2-[[(2E)-3-(2-萘基)-1-氧代-2-丁烯基]氨基]苯甲酸 |
321674-73-1 |
| ELQ－300 |
ELQ-300 |
1354745-52-0 |
| ELLIPTICINE |
椭圆玫瑰树碱 |
519-23-3 |
| DAPIVIRINE,4-[[4-(2,4,6-TRIMETHYLPHENYL)AMINO]PYRIMIDIN-2-YL]AMINO]BENZONITRILE |
达匹韦林 |
244767-67-7 |
QQ
微信
